Briefly about Santo
SANTO received three important certificates of compliance for Good Manufacturing Practice (GMP) requirements for manufacturing facilities to produce injection solutions and infusions, and the production of solid oral medicines, as well as a certificate of compliance of the pharmacy warehouse with the standard of Good Distribution Practice (GDP).
On the 15th of May, a solemn ceremony of signing the Memorandum of Cooperation between SANTO and KazNMU named after S. Asfendiyarov was held within the framework of the educational project “SANTO Academic Program” in the small hall of the Kazakh National Medical University named after S. Asfendiyarov.
SANTO launched a social project for World Heart Day (September 29) and World Thrombosis Day (October 13) to bring people’s attention to cardiovascular diseases and their prevention. At the request of SANTO, three well-known Kazakhstani music performers, who work in different genres, recorded their compositions to the rhythms of the hearts of unfamiliar or unnamed people, and only after creating the composition it became known to the sounds of whose hearts the songs had been written. Also, in Almaty and Shymkent, express medical screenings “Pulse of Life” took place, where everyone who wished to do so could determine the level of cholesterol and measure their blood pressure. The same screenings took place in several regions for two months. During the express screening "Pulse of Life" more than 2500 people were examined.
On October 29, a solemn ceremony of awarding the winners of the republican competition among Kazakhstani sculptors, architects and artists "The Code of Science and Art" was held in Almaty. The purpose of the competition was to identify the best sketches of monumental sculpture, embodying innovative technologies in health care. The “Grand Prize” of the competition was awarded to a young creative team from Almaty in the person of Dulat Ussenbayev, Aidos Burkitbayev, Kanat Beguliev, Alimzhan Tokbayev with the work “A Glance into the Future”. This sculpture will be the new symbol of the SANTO plant.
As of January 1, 2019, according to IQVIA company’s results at the end of 2018, SANTO is one of the three leaders in the pharmaceutical market in Kazakhstan and ranks first in the retail segment.
The Annual National Teleconference "New Industrialization of the Country: Leap of the Kazakhstani Leopard" took place with the participation of the President of the Republic of Kazakhstan on December 6, during which the production of solid oral medications launched at the largest pharmaceutical plant of "Chimpharm" JSC. The launch of a new production capacity of 600 million tablets per year is another victorious stage of a large-scale investment program, systematically implemented by the investor - Polpharma Group, one of the largest European pharmaceutical manufacturers.
It is noteworthy that the opening of the new production takes place on the eve of the celebration of the 135th anniversary of the plant, symbolizing the new perspectives and horizons opening before the flagship of the pharmaceutical industry in Kazakhstan.
The President Nursultan Nazarbayev had a visit to the plant of "Chimpharm" JSC in the city of Shymkent on April 22. During the visit, the President of the Republic of Kazakhstan, Nursultan Nazarbayev, opened new production lines of SANTO and got acquainted with the work of infusion lines in the department for the production of ampoules and infusions. The infusion lines that the Head of State has opened have no analogues both in the territory of the Republic of Kazakhstan and throughout Central Asia.
The second National Congress of the leading doctors of Kazakhstan "SANTO Congress" Republican Congress of Leading Practitioners of Kazakhstan SANTO Congress and 1st Conference “Pharma Practicum 2015” devoted to applied pharmacy for pharmacists, managers and owners of pharmacies in Kazakhstan took place.
The Company is exporting its products to five countries, i.e. Russia, Kyrgyzstan, Mongolia, Tajikistan and Turkmenistan and covers the demand of internal market.
The Company obtained the GMP certificate for the manufacturing site of infusion solutions.
At the end of 2015 according to IMS Health (the world's leading company in the field of information and technology services, measuring and improving the performance of companies in the medical industry) SANTO Company has become the leader of Kazakhstan pharmaceutical market in value terms with a market share of 4.27%.
Representative office has been opened in Kyrgyzstan.
1st Republican Congress of Leading Practitioners of Kazakhstan initiated by SANTO took place; Jerzy Starak, President of Supervisory Council became a member of International Investors Board operating at the Presidential office of the Republic of Kazakhstan and SANTO Company gained GMP certificate for production of solutions for injections in Injections and Infusions Department.
SANTO Company gained GMP certificate for existing Ampoules Department; launched education project SANTO Academic Programme; under the Forced Innovative-Industrial Development Programme new Parenteral Department of small and big volumes was commissioned in the plant, which has no analogues within the whole Eurasia region. Project investments comprised US$38mio. Capacities of the new complex enable to produce 300mln ampoules of injected preparations in glass ampoules annum, 2 mln packs of infusions in PE bags annum, 2 mln packs of infusions in PE vials annum.
SANTO gained GMP certificate for Aseptic Powders of Antibiotics
Chimpharm JSC merged with European Group of companies Polpharma and obtained its new trade name Santo Member of Polpharma Group.
SANTO received the first certificate of Good Manufacturing Practice (GMP) for the Soft Dosage Forms Department (ointments, oils, gels, liniments).
Implemented Enterprise Resources Planning System ERP SAP R3
Commenced production of sachets in Shymkent plant
Startup Soft Dosage Forms
Gained ISO 9001:2000
Got started the Company in stock trading at Kazakhstan Stock Exchange (IPO and KASE) and trademark of Santo enterprise was registered.
Startup third line of Solid Dosage Forms and commenced production of injections in ampoules of syringe filling.
Startup Injections in ampoules of vacuum filling and second line of Solid Dosage Forms.
Startup first line of Solid Dosage Forms and Galenics
Shymkent Plant reorganized to Chimpharm JSC.
Largest manufacture of drug substances in USSR
Foundation of Pharmaceutical Plant in Shymkent